Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Leodolter

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Gut|April 15, 2000
alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relativesJ Yu, M P Ebert, S Miehlke, et al.
Alimentary Pharmacology & Therapeutics|February 3, 2009
Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD studyM Nocon, J Labenz, D Jaspersen, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2002
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized studyUlrich Peitz, M Sulliga, K Wolle, et al.
Alimentary Pharmacology & Therapeutics|February 27, 2009
Clinical course of laryngo-respiratory symptoms in gastro-oesophageal reflux disease during routine care--a 5-year follow-upD Jaspersen, M Nocon, J Labenz, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2006
Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagusM Vieth, M Kulig, A Leodolter, et al.
European Journal of Gastroenterology & Hepatology|February 3, 2000
13C-octanoic acid breath test for gastric emptying measurementB Delbende, F Perri, O Couturier, et al.
Journal of Clinical Epidemiology|July 13, 2004
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD studyM Kulig, M Nocon, M Vieth, et al.
Alimentary Pharmacology & Therapeutics|November 11, 2011
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD studyP Malfertheiner, M Nocon, M Vieth, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2003
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD StudyD Jaspersen, M Kulig, J Labenz, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2003
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiativeM Kulig, A Leodolter, M Vieth, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Gut|April 15, 2000
alpha-catenin expression is decreased in human gastric cancers and in the gastric mucosa of first degree relativesJ Yu, M P Ebert, S Miehlke, et al.
Alimentary Pharmacology & Therapeutics|February 3, 2009
Health-related quality of life in patients with gastro-oesophageal reflux disease under routine care: 5-year follow-up results of the ProGERD studyM Nocon, J Labenz, D Jaspersen, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2002
High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized studyUlrich Peitz, M Sulliga, K Wolle, et al.
Alimentary Pharmacology & Therapeutics|February 27, 2009
Clinical course of laryngo-respiratory symptoms in gastro-oesophageal reflux disease during routine care--a 5-year follow-upD Jaspersen, M Nocon, J Labenz, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2006
Histological effects of esomeprazole therapy on the squamous epithelium of the distal oesophagusM Vieth, M Kulig, A Leodolter, et al.
European Journal of Gastroenterology & Hepatology|February 3, 2000
13C-octanoic acid breath test for gastric emptying measurementB Delbende, F Perri, O Couturier, et al.
Journal of Clinical Epidemiology|July 13, 2004
Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD studyM Kulig, M Nocon, M Vieth, et al.
Alimentary Pharmacology & Therapeutics|November 11, 2011
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD studyP Malfertheiner, M Nocon, M Vieth, et al.
Alimentary Pharmacology & Therapeutics|June 26, 2003
Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD StudyD Jaspersen, M Kulig, J Labenz, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2003
Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiativeM Kulig, A Leodolter, M Vieth, et al.
Pageof 6